diabetes drug for weight loss semaglutide Ozempic® GLP Weight-loss drug semaglutide shown to

10.7506/spkx1002-6630-20201017-154 77 LuY.CaiL.ZhuC.LiuG.ZhangY.HuangJ.et al (2017)

Consistent with the compromised function of apoE4, human carriers exhibit increased risk of CAD compared to humans expressing apoE3 or apoE2 (heterozygous) (126,132,133)

This modulation helped restore gut motility and reduce stress-induced diarrhea and ulceration

Long-term efficacy, safety & duration: While GLP-1s have shown impressive short-term results, the long-term picture remains blurry

Dng ngm c tt hn dng ung khng

While GLP-1s are generally well tolerated and offer numerous health benefits from weight loss and better glucose control to a lower risk of cardiovascular disease research suggests they could increase the risk of certain serious eye conditions